SPDR S&P Pharmaceuticals ETF Down 18.2% Since SmarTrend Downtrend Call (XPH)

SmarTrend identified a Downtrend for SPDR S&P Pharmaceuticals ETF (AMEX:XPH) on August 5th, 2015 at $64.44. In approximately 4 months, SPDR S&P Pharmaceuticals ETF has returned 18.23% as of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.